Positive impactIPO

Sahajanand Medical Technologies IPO Day 2: Check GMP, subscription status and key details

Economic Times 58 min ago·16 Oct 2026, 3:21 am

Sahajanand Medical Technologies is currently in its second day of its initial public offering (IPO). The company is offering shares to raise funds through an offer for sale, with a price band set between Rs 327 and Rs 344 per share. The total issue size is approximately Rs 475 crore. On the first day of subscription, the IPO received a 34% response from investors.

For investors, the IPO's performance will be closely watched as it marks the entry of a specialized medical device manufacturer into the public market. The company's financials show strong profitability growth, with its profit after tax (PAT) increasing by 175% to Rs 69 crore in FY26. This indicates a healthy business trajectory that could attract long-term investors.

Investors should monitor the subscription status for the remaining days and the grey market premium (GMP), which is currently at 12%. A positive trend in the grey market and strong subscription numbers could signal a good listing, while a lackluster response might dampen market sentiment for the stock.

Key takeaways

  • Category: IPO.
  • AI reads the tone as positive (potentially bullish) for the stock.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Economic Times.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.

Sahajanand Medical Technologies IPO Day 2: Check GMP, subscription status and key details